WO2023007710A1 - Method for producing (r,s)-nicotine - Google Patents

Method for producing (r,s)-nicotine Download PDF

Info

Publication number
WO2023007710A1
WO2023007710A1 PCT/JP2021/028395 JP2021028395W WO2023007710A1 WO 2023007710 A1 WO2023007710 A1 WO 2023007710A1 JP 2021028395 W JP2021028395 W JP 2021028395W WO 2023007710 A1 WO2023007710 A1 WO 2023007710A1
Authority
WO
WIPO (PCT)
Prior art keywords
nicotine
production method
formic acid
equilibrium mixture
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2021/028395
Other languages
French (fr)
Japanese (ja)
Inventor
茜 有尾
敦 永井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Tobacco Inc
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Priority to PCT/JP2021/028395 priority Critical patent/WO2023007710A1/en
Publication of WO2023007710A1 publication Critical patent/WO2023007710A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Definitions

  • the present invention relates to a method for producing (R,S)-nicotine.
  • Nicotine is a kind of alkaloid contained in plants and is a natural product. Nicotine has two optical isomers, (R)-nicotine and (S)-nicotine, and most nicotine extracted from plants is the S-isomer. By the way, various investigations have been made to chemically synthesize nicotine.
  • Patent Document 1 describes a racemic mixture of (R)-nicotine and (S)-nicotine from 1-methyl-3-nicotinoyl-2-pyrrolidone or a salt thereof using a one-pot process. S)-nicotine”) or a salt thereof.
  • Patent Document 2 describes the reaction of N-methyl-2-pyrrolidone or a salt thereof with a nicotinic acid salt compound in the presence of a solvent and a base to form 1-methyl-3-nicotinoyl-2-pyrrolidone or a salt thereof. , discloses the reduction of said 1-methyl-3-nicotinoyl-2-pyrrolidone or a salt thereof with a solution of Na 2 S 2 O 4 to produce racemic nicotine or a salt thereof.
  • Patent Document 3 discloses a method for producing racemic nicotine starting from N-vinyl-2-pyrrolidinone and a nicotinic acid ester.
  • an object of the present invention is to provide a method for producing (R,S)-nicotine by a simpler method.
  • Aspect 1 A method for producing (R,S)-nicotine, comprising subjecting an equilibrium mixture of pseudooxynicotine to a reaction with formic acid.
  • Aspect 2 The production method according to aspect 1, wherein the step comprises selectively reducing a compound represented by formula (a) described below from an equilibrium mixture of pseudooxynicotine.
  • Aspect 3 The production method according to aspect 1 or 2, wherein the step does not use a metal as a catalyst.
  • Aspect 4 The production method according to any one of aspects 1 to 3, wherein substantially no amino alcohol is produced in the step.
  • Aspect 5 The production method according to any one of aspects 1 to 4, wherein in said step, an equimolar amount or more of formic acid is used with respect to the total molar amount of said equilibrium mixture.
  • Aspect 6 The production method according to any one of aspects 1 to 5, wherein the step does not use an additional basic substance.
  • Aspect 7 The production method according to any one of aspects 1 to 6, wherein no solvent is used in the steps.
  • Aspect 8 (R,S)-nicotine obtained by the production method according to any one of aspects 1 to 7.
  • X to Y includes X and Y which are the end values.
  • the method of manufacture comprises the step of subjecting an equilibrium mixture of pseudooxynicotine to a reaction with formic acid.
  • an equilibrium mixture of pseudooxynicotine is used as a starting material.
  • Pseudooxynicotine is a compound represented by PON in the following formula.
  • Pseudooxynicotine exists as an equilibrium mixture under the conditions used in this production method (Patent Document 4: International Publication No. 2014/174505).
  • the conditions used in this production method are not limited as long as the above reaction can be carried out, but in one embodiment, the conditions are room temperature or higher and normal pressure.
  • the mixture of the four compounds in the scheme below is referred to as the pseudooxynicotine equilibrium mixture or simply the equilibrium mixture.
  • Pseudooxynicotine can be produced by a known method, for example, a method of reacting N-methyl-2-pyrrolidone or a salt thereof with a nicotinic acid salt compound in the presence of a solvent and a base, followed by acid hydrolysis and alkalinization. is mentioned.
  • compound a in the equilibrium mixture is selectively reduced by formic acid to produce (R,S)-nicotine.
  • compound a is converted to (R,S)-nicotine, it is presumed that compound a is sequentially supplied from the equilibrium mixture because the equilibrium is biased. That is, in this production method, the equilibrium mixture and formic acid are present in the reaction system, and compound a is selectively converted to (R,S)-nicotine.
  • the amount of formic acid is theoretically equimolar or greater than the molar amount of pseudooxynicotine, that is, the total molar amount of the equilibrium mixture (the total molar amount of pseudooxynicotine, compound 1, compound b, and compound a). Any amount is sufficient, but it is preferably 1.5-fold molar amount or more, more preferably 2-fold molar amount or more.
  • the upper limit is not limited, but is preferably 100-fold molar amount or less, 50-fold molar amount or less, 40-fold molar amount or less, 30-fold molar amount or less, 20-fold molar amount or less, or 10-fold molar amount or less. It is preferably not more than 5 times the molar amount.
  • a solvent may be used in this step. When a solvent is used, the upper limit of the amount of formic acid can be less than or equal to the amount of solvent.
  • (R,S)-nicotine can be produced without using metals.
  • the metal here means a metal that participates in the reaction, such as a catalyst, and does not include metals that do not participate in the reaction, such as metals used as materials for reactors. Therefore, in this step, it is preferable not to use a metal involved in the reaction, and more preferably not to use a metal as a catalyst.
  • carbonyl and imino groups cannot be reduced by hydrogen sources such as formic acid alone.
  • the reduction requires the use of a boranate complex or a specific transition metal to generate active hydrogen.
  • the inventors have surprisingly found that said reduction can be carried out without the use of metals as catalysts. The reason for this is presumed to be that a hydride equivalent derived from formic acid is produced in this step, as described above.
  • the step of removing the metal can be omitted or simplified.
  • compounds other than compound a in the equilibrium mixture are also reduced, resulting in the formation of by-products.
  • the isolation step can be simplified or omitted.
  • Additional basic substances are pseudooxynicotine, compound 1, compound a, compound b, (R,S)-nicotine, and basic substances other than solvents.
  • the basic substance generates hydride by abstracting the hydrogen from the carboxylic acid site of formic acid, making formic acid an active species.
  • the reduction can be carried out without additional basic substances. Therefore, compared with the method of adding an additional basic substance, it can be carried out at low cost under mild and convenient conditions.
  • the reason why it is not necessary to use an additional basic substance is not limited, but it is presumed that the substrate itself or the product itself functions as a base. However, if necessary, an additional basic substance may be used within a range that does not impair the effects of the present invention. Examples of the basic substance include triethylamine and pyridine.
  • This step can be carried out at room temperature (about 10 to 30°C) or higher.
  • the upper limit of the temperature is not limited, it can be, for example, reflux conditions.
  • this step can be carried out at normal pressure.
  • the atmosphere in which this step is performed is not limited, it is preferably an inert atmosphere.
  • This step can be performed without a solvent or in the presence of a solvent.
  • Solvents that can be used are not limited, but include, for example, aprotic solvents such as dimethylformamide, acetonitrile, tetrahydrofuran, dichloromethane, 1,4-dioxane, and alcohols such as ethanol.
  • aprotic solvents such as dimethylformamide, acetonitrile, tetrahydrofuran, dichloromethane, 1,4-dioxane
  • alcohols such as ethanol.
  • aminoalcohols which are by-products
  • Substantially no by-products means that the target product does not contain 100 ppm or more of by-products in one aspect.
  • a compound presumed to be an amino alcohol by-product was not detected on TLC.
  • the content of by-products can be said to be less than 100 ppm. Therefore, (R,S)-nicotine can be obtained in high yield by this production method.
  • An aminoalcohol is a compound having an alkane skeleton containing a hydroxy group and an amino group, and in one aspect, is a compound having the following structure.
  • the production method may further include a known purification step.
  • this production method may further comprise a step of separating the R-isomer or S-isomer from the obtained (R,S)-nicotine.
  • the compound represented by the formula (A) can also be used as a starting material in this production method.
  • X - is a counter anion.
  • the anion is not limited and may be an organic anion or an inorganic anion, preferably an inorganic anion.
  • examples of the inorganic anion include OH ⁇ , and halide ions such as Cl ⁇ , Br ⁇ and I ⁇ , and OH ⁇ is more preferable.
  • (R,S)-Nicotine The (R,S)-nicotine obtained by this production method has the advantage of containing extremely few impurities as described above. Therefore, (R,S)-nicotine is useful in fields such as pharmaceuticals and smoking articles.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Provided is a method for producing (R,S)-nicotine which includes a step in which an equilibrium mixture of pseudooxynicotines is reacted with formic acid. The step preferably includes selectively reducing the compound represented by formula (a) out of the equilibrium mixture of pseudooxynicotines.

Description

(R,S)-ニコチンの製造方法Method for producing (R,S)-nicotine

 本発明は、(R,S)-ニコチンの製造方法に関する。 The present invention relates to a method for producing (R,S)-nicotine.

 ニコチンは植物に含まれるアルカロイドの一種であり天然物である。ニコチンには(R)-ニコチンと(S)-ニコチンの2つの光学異性体があり、植物から抽出されるニコチンのほとんどがS体である。ところでニコチンを化学的に合成することが種々検討されている。例えば特許文献1は、1-メチル-3-ニコチノイル-2-ピロリドンまたはその塩からワンポットプロセスを用いてラセミニコチン((R)-ニコチンと(S)-ニコチンのラセミ混合体。以下「(R,S)-ニコチン」ともいう。)またはその塩を製造する方法を開示する。特許文献2は、溶媒および塩基の存在下において、N-メチル-2-ピロリドンまたはその塩を、ニコチン酸塩化合物と反応させて1-メチル-3-ニコチノイル-2-ピロリドンまたはその塩を形成し、当該1-メチル-3-ニコチノイル-2-ピロリドンまたはその塩を、Naの溶液を用いて還元して、ラセミニコチンまたはその塩を製造することを開示する。特許文献3は、N-ビニル-2-ピロリジノンとニコチン酸エステルを出発物とし、ラセミニコチンを製造する方法を開示する。 Nicotine is a kind of alkaloid contained in plants and is a natural product. Nicotine has two optical isomers, (R)-nicotine and (S)-nicotine, and most nicotine extracted from plants is the S-isomer. By the way, various investigations have been made to chemically synthesize nicotine. For example, Patent Document 1 describes a racemic mixture of (R)-nicotine and (S)-nicotine from 1-methyl-3-nicotinoyl-2-pyrrolidone or a salt thereof using a one-pot process. S)-nicotine”) or a salt thereof. Patent Document 2 describes the reaction of N-methyl-2-pyrrolidone or a salt thereof with a nicotinic acid salt compound in the presence of a solvent and a base to form 1-methyl-3-nicotinoyl-2-pyrrolidone or a salt thereof. , discloses the reduction of said 1-methyl-3-nicotinoyl-2-pyrrolidone or a salt thereof with a solution of Na 2 S 2 O 4 to produce racemic nicotine or a salt thereof. Patent Document 3 discloses a method for producing racemic nicotine starting from N-vinyl-2-pyrrolidinone and a nicotinic acid ester.

米国特許第8884021号明細書U.S. Pat. No. 8,884,021 米国特許第9809567号明細書U.S. Pat. No. 9,809,567 米国特許第9556142号明細書U.S. Pat. No. 9,556,142 国際公開第2014/174505号WO2014/174505

 (R,S)-ニコチン(ラセミニコチン)をより簡便な方法で製造することへの要求が存在する。かかる事情に鑑み、本発明は、より簡便な方法で(R,S)-ニコチンを製造する方法を提供することを課題とする。 There is a demand for producing (R, S)-nicotine (racemic nicotine) by a simpler method. In view of such circumstances, an object of the present invention is to provide a method for producing (R,S)-nicotine by a simpler method.

 発明者らは、シュードオキシニコチンの平衡混合物をギ酸との反応に供することで、前記課題を解決できることを見出した。すなわち、前記課題は以下の本発明によって解決される。
態様1
 シュードオキシニコチンの平衡混合物を、ギ酸との反応に供する工程を備える、(R,S)-ニコチンの製造方法。
態様2
 前記工程が、シュードオキシニコチンの平衡混合物の中から後述する式(a)で表される化合物を選択的に還元することを含む、態様1に記載の製造方法。
態様3
 前記工程において、触媒としての金属を使用しない、態様1または2に記載の製造方法。
態様4
 前記工程において、アミノアルコールが実質的に生成しない、態様1~3のいずれかに記載の製造方法。
態様5
 前記工程において、前記平衡混合物の合計モル量に対し、等モル量以上のギ酸を使用する、態様1~4のいずれかに記載の製造方法。
態様6
 前記工程において、追加の塩基性物質を使用しない、態様1~5のいずれかに記載の製造方法。
態様7
 前記工程において、溶媒を使用しない、態様1~6のいずれかに記載の製造方法。
態様8
 態様1~7のいずれかに記載の製造方法で得られた(R,S)-ニコチン。
The inventors have found that the problem can be solved by subjecting an equilibrium mixture of pseudooxynicotine to a reaction with formic acid. That is, the above problems are solved by the present invention described below.
Aspect 1
A method for producing (R,S)-nicotine, comprising subjecting an equilibrium mixture of pseudooxynicotine to a reaction with formic acid.
Aspect 2
The production method according to aspect 1, wherein the step comprises selectively reducing a compound represented by formula (a) described below from an equilibrium mixture of pseudooxynicotine.
Aspect 3
The production method according to aspect 1 or 2, wherein the step does not use a metal as a catalyst.
Aspect 4
The production method according to any one of aspects 1 to 3, wherein substantially no amino alcohol is produced in the step.
Aspect 5
The production method according to any one of aspects 1 to 4, wherein in said step, an equimolar amount or more of formic acid is used with respect to the total molar amount of said equilibrium mixture.
Aspect 6
The production method according to any one of aspects 1 to 5, wherein the step does not use an additional basic substance.
Aspect 7
The production method according to any one of aspects 1 to 6, wherein no solvent is used in the steps.
Aspect 8
(R,S)-nicotine obtained by the production method according to any one of aspects 1 to 7.

 本発明によれば、より簡便な方法で(R,S)-ニコチンを製造する方法を提供できる。 According to the present invention, it is possible to provide a method for producing (R,S)-nicotine by a simpler method.

 以下、本発明を詳細に説明する。本発明において「X~Y」はその端値であるXおよびYを含む。 The present invention will be described in detail below. In the present invention, "X to Y" includes X and Y which are the end values.

1.製造方法
 本製造方法は、シュードオキシニコチンの平衡混合物をギ酸との反応に供する工程を備える。
(1)シュードオキシニコチンの平衡混合物
 本製造方法では、原料としてシュードオキシニコチンの平衡混合物を用いる。シュードオキシニコチンは、下記式中PONで表される化合物である。シュードオキシニコチンは、本製造方法で用いる条件では平衡混合物として存在する(特許文献4:国際公開第2014/174505号)。本製造方法で用いる条件とは、前記反応が実施できる条件であれば限定されないが、一態様において室温以上、かつ常圧である。本発明においては、下記スキームの4つの化合物の混合物を、シュードオキシニコチンの平衡混合物または単に平衡混合物と称する。シュードオキシニコチンは公知の方法で製造でき、例えば、溶媒および塩基の存在下において、Nメチル-2-ピロリドンまたはその塩を、ニコチン酸塩化合物と反応させ、次いで酸加水分解、アルカリ化を行う方法が挙げられる。
1. Method of Manufacture The method of manufacture comprises the step of subjecting an equilibrium mixture of pseudooxynicotine to a reaction with formic acid.
(1) Equilibrium mixture of pseudooxynicotine In this production method, an equilibrium mixture of pseudooxynicotine is used as a starting material. Pseudooxynicotine is a compound represented by PON in the following formula. Pseudooxynicotine exists as an equilibrium mixture under the conditions used in this production method (Patent Document 4: International Publication No. 2014/174505). The conditions used in this production method are not limited as long as the above reaction can be carried out, but in one embodiment, the conditions are room temperature or higher and normal pressure. In the present invention, the mixture of the four compounds in the scheme below is referred to as the pseudooxynicotine equilibrium mixture or simply the equilibrium mixture. Pseudooxynicotine can be produced by a known method, for example, a method of reacting N-methyl-2-pyrrolidone or a salt thereof with a nicotinic acid salt compound in the presence of a solvent and a base, followed by acid hydrolysis and alkalinization. is mentioned.

Figure JPOXMLDOC01-appb-C000002
Figure JPOXMLDOC01-appb-C000002

(2)ギ酸
 本製造方法では、反応基質としてギ酸を用いる。前記平衡混合物をギ酸との反応に供することで、(R,S)-ニコチンが生成する。この反応メカニズムは限定されないが、以下のように推察される。前記平衡混合物中の(a)で表される化合物(以下「化合物a」ともいう、他の化合物についても同様)は4級アンモニウムイオンとカウンターアニオンOHを有する。ギ酸が化合物aに接近した際、化合物aのヒドロキシイオンによってギ酸は活性化され、実質的にヒドリド等価体となる。当該ヒドリド等価体が近傍に存在するイミニウムイオンを還元することによって(R,S)-ニコチンが生成する。したがって、前記平衡混合物中の化合物aが、ギ酸によって選択的に還元されて(R,S)-ニコチンが生成する。化合物aが(R,S)-ニコチンに転化されると、平衡が偏るため、平衡混合物から逐次的に化合物aが供給されると推察される。すなわち、本製造方法は前記平衡混合物とギ酸を反応系に存在させ、化合物aを選択的に(R,S)-ニコチンに転化する。
(2) Formic acid In this production method, formic acid is used as a reaction substrate. Subjecting the equilibrium mixture to reaction with formic acid produces (R,S)-nicotine. Although this reaction mechanism is not limited, it is speculated as follows. The compound represented by (a) in the equilibrium mixture (hereinafter also referred to as "compound a"; the same applies to other compounds) has a quaternary ammonium ion and a counter anion OH - . When formic acid approaches compound a, formic acid is activated by the hydroxy ions of compound a, essentially becoming a hydride equivalent. (R,S)-nicotine is produced by the reduction of the iminium ion in the vicinity of the hydride equivalent. Therefore, compound a in the equilibrium mixture is selectively reduced by formic acid to produce (R,S)-nicotine. When compound a is converted to (R,S)-nicotine, it is presumed that compound a is sequentially supplied from the equilibrium mixture because the equilibrium is biased. That is, in this production method, the equilibrium mixture and formic acid are present in the reaction system, and compound a is selectively converted to (R,S)-nicotine.

 したがってギ酸の量は、シュードオキシニコチンのモル量、すなわち平衡混合物の合計モル量(シュードオキシニコチン、化合物1、化合物b、および化合物aの合計モル量)に対し、理論上、等モル量以上であればよいが、好ましくは1.5倍モル量以上であり、より好ましくは2倍モル量以上である。その上限は限定されないが、好ましくは、100倍モル量以下、50倍モル量以下、40倍モル量以下、30倍モル量以下、20倍モル量以下、または10倍モル量以下であり、最も好ましくは5倍モル量以下である。また、後述するとおり、本工程においては溶媒を用いてもよい。溶媒を用いる場合、ギ酸の量の上限は、溶媒の量以下とすることができる。 Therefore, the amount of formic acid is theoretically equimolar or greater than the molar amount of pseudooxynicotine, that is, the total molar amount of the equilibrium mixture (the total molar amount of pseudooxynicotine, compound 1, compound b, and compound a). Any amount is sufficient, but it is preferably 1.5-fold molar amount or more, more preferably 2-fold molar amount or more. The upper limit is not limited, but is preferably 100-fold molar amount or less, 50-fold molar amount or less, 40-fold molar amount or less, 30-fold molar amount or less, 20-fold molar amount or less, or 10-fold molar amount or less. It is preferably not more than 5 times the molar amount. Further, as described later, a solvent may be used in this step. When a solvent is used, the upper limit of the amount of formic acid can be less than or equal to the amount of solvent.

(3)金属
 本工程においては、金属を使用することなく(R,S)-ニコチンを生成できる。ここでの金属は、触媒等の反応に関与する金属を意味し、反応に関与しない金属、例えば反応器の素材としての金属は対象外である。したがって、本工程においては反応に関与する金属を用いないことが好ましく、触媒としての金属を用いないことがより好ましい。従来、カルボニル基やイミノ基をギ酸のような水素源のみで還元することはできないと理解されてきた。例えば特許文献1に記載のとおり、当該還元には、ボランアート錯体や特定の遷移金属を用いて活性水素を生成させる必要があった。しかし、発明者らは、驚くべきことに触媒として金属を使用することなく前記還元を実施できることを見出した。この理由は、前述のとおり本工程ではギ酸に由来するヒドリド等価体が生成するためと推察される。
(3) Metals In this step, (R,S)-nicotine can be produced without using metals. The metal here means a metal that participates in the reaction, such as a catalyst, and does not include metals that do not participate in the reaction, such as metals used as materials for reactors. Therefore, in this step, it is preferable not to use a metal involved in the reaction, and more preferably not to use a metal as a catalyst. Conventionally, it has been understood that carbonyl and imino groups cannot be reduced by hydrogen sources such as formic acid alone. For example, as described in Patent Document 1, the reduction requires the use of a boranate complex or a specific transition metal to generate active hydrogen. However, the inventors have surprisingly found that said reduction can be carried out without the use of metals as catalysts. The reason for this is presumed to be that a hydride equivalent derived from formic acid is produced in this step, as described above.

 触媒として金属を用いる場合には、最終生成物の金属許容限度値の観点からこれを除去する必要がある。本工程において金属を用いない場合、金属を除去する工程を省略または簡略化できる。また、触媒として金属を用いると平衡混合物における化合物a以外の化合物も還元されてしまうため、副生成物が生成するが、当該金属を用いない場合、単離工程を簡略化または省略できる。 When using metals as catalysts, it is necessary to remove them from the perspective of metal tolerance limits in the final product. If no metal is used in this step, the step of removing the metal can be omitted or simplified. In addition, when a metal is used as a catalyst, compounds other than compound a in the equilibrium mixture are also reduced, resulting in the formation of by-products. However, when the metal is not used, the isolation step can be simplified or omitted.

(4)塩基性物質
 本工程では、追加の塩基性物質を使用しないことができる。追加の塩基性物質とは、シュードオキシニコチン、化合物1、化合物a、化合物b、(R,S)-ニコチン、および溶媒以外の塩基性物質である。
(4) Basic substance No additional basic substance may be used in this step. Additional basic substances are pseudooxynicotine, compound 1, compound a, compound b, (R,S)-nicotine, and basic substances other than solvents.

 塩基性物質は、ギ酸のカルボン酸部位の水素を引き抜くことによってヒドリドを生じさせて、ギ酸を活性種とする。しかし本工程では、追加の塩基性物質を用いることなく還元を実施できる。このため、追加の塩基性物質を添加する方法と比較して安価に、穏和かつ簡便な条件で実施できる。追加の塩基性物質を用いる必要がない理由は限定されないが、基質自体あるいは生成物自体が塩基として機能するためと推定される。ただし、必要に応じ、本発明の効果を損なわない範囲で追加の塩基性物質を使用してもよい。当該塩基性物質としてはトリエチルアミンまたはピリジン等が挙げられる。 The basic substance generates hydride by abstracting the hydrogen from the carboxylic acid site of formic acid, making formic acid an active species. However, in this step the reduction can be carried out without additional basic substances. Therefore, compared with the method of adding an additional basic substance, it can be carried out at low cost under mild and convenient conditions. The reason why it is not necessary to use an additional basic substance is not limited, but it is presumed that the substrate itself or the product itself functions as a base. However, if necessary, an additional basic substance may be used within a range that does not impair the effects of the present invention. Examples of the basic substance include triethylamine and pyridine.

(5)条件
 本工程は室温(10~30℃程度)またはそれよりも高い温度で実施できる。温度の上限は限定されないが、例えば還流条件下とすることができる。また、本工程は常圧で実施できる。さらに、本工程を実施する雰囲気は限定されないが、不活性雰囲気下であることが好ましい。
(5) Conditions This step can be carried out at room temperature (about 10 to 30°C) or higher. Although the upper limit of the temperature is not limited, it can be, for example, reflux conditions. Moreover, this step can be carried out at normal pressure. Furthermore, although the atmosphere in which this step is performed is not limited, it is preferably an inert atmosphere.

 本工程は無溶媒で行うこともできるし、溶媒存在下で行うこともできる。使用できる溶媒は限定されないが、例えばジメチルホルムアミド、アセトニトリル、テトラヒドロフラン、ジクロロメタン、1,4-ジオキサン等の非プロトン性溶媒、またはエタノール等のアルコールが挙げられる。反応場として溶媒が存在する方が、反応効率が高くなる。 This step can be performed without a solvent or in the presence of a solvent. Solvents that can be used are not limited, but include, for example, aprotic solvents such as dimethylformamide, acetonitrile, tetrahydrofuran, dichloromethane, 1,4-dioxane, and alcohols such as ethanol. The presence of a solvent as a reaction field increases the reaction efficiency.

(6)副生成物
 本工程では、副生成物であるアミノアルコールが実質的に生成しないという利点もある。副生成物が実質的に生成しないとは、一態様において目的生成物が100ppm以上の副生成物を含有しないことをいう。例えば実施例1において、副生成物であるアミノアルコールと推測される化合物はTLC上では検出されなかった。この場合、TLCの検出限界を考慮すると、副生成物の含有量は100ppm未満といえる。したがって本製造方法により、高い収率で(R,S)-ニコチンを得ることができる。なお、アミノアルコールとは、ヒドロキシ基およびアミノ基を含有するアルカン骨格を有する化合物であり、一態様において以下の構造を有する化合物である。
(6) By-products This step also has the advantage that aminoalcohols, which are by-products, are not substantially produced. Substantially no by-products means that the target product does not contain 100 ppm or more of by-products in one aspect. For example, in Example 1, a compound presumed to be an amino alcohol by-product was not detected on TLC. In this case, considering the detection limit of TLC, the content of by-products can be said to be less than 100 ppm. Therefore, (R,S)-nicotine can be obtained in high yield by this production method. An aminoalcohol is a compound having an alkane skeleton containing a hydroxy group and an amino group, and in one aspect, is a compound having the following structure.

Figure JPOXMLDOC01-appb-C000003
Figure JPOXMLDOC01-appb-C000003

(7)その他
 本製造方法は、公知の精製工程をさらに備えていてもよい。また、本製造方法は得られた(R,S)-ニコチンから、R体またはS体を分離する工程をさらに備えていてもよい。
(7) Others The production method may further include a known purification step. In addition, this production method may further comprise a step of separating the R-isomer or S-isomer from the obtained (R,S)-nicotine.

 また、本製造方法は原料として式(A)で表される化合物を用いることもできる。

Figure JPOXMLDOC01-appb-C000004
In addition, the compound represented by the formula (A) can also be used as a starting material in this production method.
Figure JPOXMLDOC01-appb-C000004

 式中、Xはカウンターアニオンである。当該アニオンは限定されず、有機アニオンまたは無機アニオンであってよいが、好ましくは無機アニオンである。当該無機アニオンとしては、OH、または、Cl、Br、I等のハロゲン化物イオン等が挙げられ、中でもOHであることがより好ましい。 In the formula, X - is a counter anion. The anion is not limited and may be an organic anion or an inorganic anion, preferably an inorganic anion. Examples of the inorganic anion include OH , and halide ions such as Cl , Br and I , and OH is more preferable.

2.(R,S)-ニコチン
 本製造方法で得られる(R,S)-ニコチンは、前述のとおり不純物が極めて少ないという利点を有する。よって、(R,S)-ニコチンは、医薬および喫煙物品等の分野において有用である。
2. (R,S)-Nicotine The (R,S)-nicotine obtained by this production method has the advantage of containing extremely few impurities as described above. Therefore, (R,S)-nicotine is useful in fields such as pharmaceuticals and smoking articles.

[製造例1]シュードオキシニコチンの合成
 二口ナスフラスコに2.4gのNaH(100mmol、2.0eq)を加え、30mLのトルエンで2回洗浄し、活性化させた。当該フラスコ内に10mLのシクロペンチルメチルエーテル(CPME)を加えた後、5.0g(50mmol、1.0等量)のN-メチルピロリドンを20mLのCPMEに溶解した溶液を加えて60℃で30分間撹拌した。次いで、フラスコ内に9.1gのニコチン酸エチル(60mmol、1.2等量)を20mLのCPMEに溶解した溶液を加え、85℃で加熱撹拌し反応を行った。反応終了後、6MのHClを加えて中和し、中性になったことを確認してから酢酸エチルで中間体1(8.8g、収率86%)を抽出した。
[Production Example 1] Synthesis of pseudooxynicotine 2.4 g of NaH (100 mmol, 2.0 eq) was added to a two-necked eggplant flask, washed twice with 30 mL of toluene, and activated. After adding 10 mL of cyclopentyl methyl ether (CPME) into the flask, add a solution of 5.0 g (50 mmol, 1.0 equivalent) of N-methylpyrrolidone dissolved in 20 mL of CPME, and heat at 60° C. for 30 minutes. Stirred. Then, a solution of 9.1 g of ethyl nicotinate (60 mmol, 1.2 equivalents) dissolved in 20 mL of CPME was added to the flask, and the mixture was heated and stirred at 85° C. for reaction. After completion of the reaction, 6M HCl was added for neutralization, and after confirming neutrality, intermediate 1 (8.8 g, yield 86%) was extracted with ethyl acetate.

 4gの当該中間体1(20mmol)に対して6MのHSOを50mL添加し、72時間リフラックス加熱した。反応終了後、pHが13になるまで水酸化ナトリウムを加えた。当該反応液を、エーテルを用いて分液し、ブラインを用いてを洗浄後、硫酸マグネシウムを用いて有機相を乾燥した。当該有機相から、ロータリーエバポレーターを用いて溶媒を留去し、目的のシュードオキシニコチンを56%の収率で得た。 50 mL of 6 M H 2 SO 4 was added to 4 g of the intermediate 1 (20 mmol) and heated under reflux for 72 hours. After completion of the reaction, sodium hydroxide was added until the pH reached 13. The reaction was partitioned with ether, washed with brine, and the organic phase was dried with magnesium sulfate. The solvent was distilled off from the organic phase using a rotary evaporator to obtain the desired pseudooxynicotine in a yield of 56%.

[実施例1]ギ酸を用いた(R,S)-ニコチンの合成
 178.2mgの前記シュードオキシニコチン(1mmol、1等量)を、二口20mLナスフラスコに秤量した。これに対し0.12mLのギ酸(3.2mmol、3.2等量)、6mLのジメチルホルムアミドおよび0.36mLのトリエチルアミン(2.6mmol、2.6等量)を加え、室温で撹拌し反応を行った。反応終了後、ロータリーエバポレーターを用いて余剰のギ酸を留去して、目的の(R,S)-ニコチンを得た。収率は78%であった。当該収率は、平衡混合物がすべて化合物aであると仮定して算出した。副生成物であるアミノアルコールは、TLCでは検出されなかった。このように、シュードオキシニコチンの平衡混合物の中から化合物aが選択的に還元されて(R,S)-ニコチンを製造できた。
[Example 1] Synthesis of (R,S)-nicotine using formic acid 178.2 mg of the pseudooxynicotine (1 mmol, 1 equivalent) was weighed into a two-necked 20 mL eggplant flask. To this was added 0.12 mL formic acid (3.2 mmol, 3.2 eq), 6 mL dimethylformamide and 0.36 mL triethylamine (2.6 mmol, 2.6 eq) and stirred at room temperature to allow the reaction to proceed. gone. After completion of the reaction, excess formic acid was distilled off using a rotary evaporator to obtain the desired (R,S)-nicotine. Yield was 78%. The yield was calculated assuming the equilibrium mixture was all compound a. The by-product aminoalcohol was not detected by TLC. Thus, compound a could be selectively reduced from an equilibrium mixture of pseudooxynicotine to produce (R,S)-nicotine.

[比較例1]
 ギ酸の代わりに酢酸を用いた以外は、実施例1と同じ方法で(R,S)-ニコチンの合成を試みた。しかし、(R,S)-ニコチンは生成しなかった。
[Comparative Example 1]
An attempt was made to synthesize (R,S)-nicotine in the same manner as in Example 1, except that acetic acid was used instead of formic acid. However, (R,S)-nicotine was not produced.

Claims (8)

 シュードオキシニコチンの平衡混合物を、ギ酸との反応に供する工程を備える、(R,S)-ニコチンの製造方法。 A method for producing (R,S)-nicotine, comprising the step of subjecting an equilibrium mixture of pseudooxynicotine to a reaction with formic acid.  前記工程が、シュードオキシニコチンの平衡混合物の中から式(a)で表される化合物を選択的に還元することを含む、
Figure JPOXMLDOC01-appb-C000001
請求項1に記載の製造方法。
said step comprising selectively reducing a compound of formula (a) from an equilibrium mixture of pseudooxynicotine;
Figure JPOXMLDOC01-appb-C000001
The manufacturing method according to claim 1.
 前記工程において、触媒としての金属を使用しない、請求項1または2に記載の製造方法。 The production method according to claim 1 or 2, wherein the step does not use a metal as a catalyst.  前記工程において、アミノアルコールが実質的に生成しない、請求項1~3のいずれかに記載の製造方法。 The production method according to any one of claims 1 to 3, wherein substantially no amino alcohol is produced in the step.  前記工程において、前記平衡混合物の合計モル量に対し、等モル量以上のギ酸を使用する、請求項1~4のいずれかに記載の製造方法。 The production method according to any one of claims 1 to 4, wherein in said step, an equimolar amount or more of formic acid is used with respect to the total molar amount of said equilibrium mixture.  前記工程において、追加の塩基性物質を使用しない、請求項1~5のいずれかに記載の製造方法。 The production method according to any one of claims 1 to 5, wherein no additional basic substance is used in said step.  前記工程において、溶媒を使用しない、請求項1~6のいずれかに記載の製造方法。 The production method according to any one of claims 1 to 6, wherein no solvent is used in the steps.  請求項1~7のいずれかに記載の製造方法で得られた(R,S)-ニコチン。 (R,S)-nicotine obtained by the production method according to any one of claims 1 to 7.
PCT/JP2021/028395 2021-07-30 2021-07-30 Method for producing (r,s)-nicotine Ceased WO2023007710A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2021/028395 WO2023007710A1 (en) 2021-07-30 2021-07-30 Method for producing (r,s)-nicotine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2021/028395 WO2023007710A1 (en) 2021-07-30 2021-07-30 Method for producing (r,s)-nicotine

Publications (1)

Publication Number Publication Date
WO2023007710A1 true WO2023007710A1 (en) 2023-02-02

Family

ID=85086546

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/028395 Ceased WO2023007710A1 (en) 2021-07-30 2021-07-30 Method for producing (r,s)-nicotine

Country Status (1)

Country Link
WO (1) WO2023007710A1 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014174505A2 (en) * 2013-04-22 2014-10-30 Perrigo Api Ltd. A process for the preparation of nicotine comprising the enzymatic reduction of 4- (methylamino) -1- (pyridin-3- yl) butan-1-one
CN110627769A (en) * 2019-09-27 2019-12-31 深圳黑尔格科技有限公司 Iminium salt derivative, process for producing the same, and process for producing nicotine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014174505A2 (en) * 2013-04-22 2014-10-30 Perrigo Api Ltd. A process for the preparation of nicotine comprising the enzymatic reduction of 4- (methylamino) -1- (pyridin-3- yl) butan-1-one
CN110627769A (en) * 2019-09-27 2019-12-31 深圳黑尔格科技有限公司 Iminium salt derivative, process for producing the same, and process for producing nicotine

Similar Documents

Publication Publication Date Title
CN111662325B (en) Method for preparing L-glufosinate-ammonium
JP6966656B2 (en) Intermediates of optically active piperidine derivatives and methods for producing them
CN110627769A (en) Iminium salt derivative, process for producing the same, and process for producing nicotine
US20110207928A1 (en) Purification method for adefovir dipivoxil
CN111233829A (en) Preparation method of nicotine with optical activity
JP2016528271A (en) □ Synthesis of biphenylalaninol via a novel intermediate
JP2005500322A (en) Method for producing 3-phenylisoserine
CN118772081B (en) A method for preparing N-methyl-2,3-dihydrobenzothiazin-4-one
EP3498695B1 (en) Method for synthesizing 3-(difluoromethyl)-1-methyl-1h-pyrazole-4-carboxylic acid
JP2009062360A (en) Method for producing cinacalcet
JP2009062360A6 (en) Cinacalcet manufacturing method
US8779192B2 (en) Process of preparing an alkylamine derivative
WO2023007710A1 (en) Method for producing (r,s)-nicotine
AU2005257478B2 (en) Method for producing (Z)-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl cyclopropane hydrochloride
US8680332B2 (en) Disubstituted-aminodifluorosulfinium salts, process for preparing same and method of use as deoxofluorination reagents
JP2004511475A (en) Method for producing racemic thioctic acid
JP6228210B2 (en) Method for purifying fluvoxamine free base and method for producing high purity fluvoxamine maleate using the same
JP2000204094A (en) Production of amineborane
US10815263B2 (en) Method for purifying P1,P4-di(uridine 5′-)tetraphosphate
CN111848423A (en) Preparation method of tert-butyl 3-oxocyclobutylcarbamate
WO2023007712A1 (en) (r,s)-nicotine production method
WO2002032852A2 (en) Synthesis of acid addition salt of delta-aminolevulinic acid from 5-bromo levulinic acid esters
US9573896B2 (en) Methods for preparing d-threo-methylphenidate using diazomethane, and compositions thereof
JP4802191B2 (en) Optically active quaternary ammonium salt having axial asymmetry and method for producing α-amino acid and derivatives thereof using the same
CN117142934B (en) Preparation method of (S) -3-cyclohexene-1-formic acid and intermediate thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21951909

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21951909

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP